Lung and oesophageal cancer Cancer Oesophageal cancer
Conditions
Interventions
Patients receive a QoL diary which consists of a core questionnaire (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer patients [EORTC QLQ C-30]) with
Sponsors
Queen's University Belfast (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inoperable lung and oesophageal cancer 2. World Health Organisation (WHO) performance status of zero to two 3. No cognitive impairment
Exclusion criteria
Exclusion criteria: 1. Surgically resectable patients 2. WHO performance status of 3+ 3. Cognitively impaired patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is QoL, measured through two questionnaires: 1. Functional Assessment of Cancer Therapy - General questionnaire (FACT-G) with lung and oesophageal modules, measured at the end of month two and month four following recruitment 2. Palliative care quality of life index, measured at the end of month two and month four following recruitment | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include: 1. Indices of patient satisfaction, measured at the end of month two and month four following recruitment 2. Impact on carers, measured at the end of month two and month four following recruitment 3. Measures of communication, measured at the end of month two and month four following recruitment 4. Multi-disciplinary nature of patient management, measured at the end of month two and month four following recruitment | — |
Countries
United Kingdom
Outcome results
None listed